1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Texas >
  6. Colossal Acquires Viagen Pets

M&A Deal Summary

Colossal Acquires Viagen Pets

On November 4, 2025, Colossal acquired life science company Viagen Pets

Acquisition Highlights
  • This is Colossal’s 1st transaction in the Life Science sector.
  • This is Colossal’s 1st transaction in the United States.
  • This is Colossal’s 1st transaction in Texas.

M&A Deal Summary
Date 2025-11-04
Target Viagen Pets
Sector Life Science
Buyer(s) Colossal
Deal Type Add-on Acquisition

Target

Viagen Pets

Cedar Park, Texas, United States
Viagen Pets provides animal genetic preservation and cloning services for companion animals and horses. Viagen Pets’ offerings include tissue banking, DNA storage, and cloning procedures for dogs, cats, and equines, as well as conservation programs for endangered species. Viagen Pets was founded in 2002 and is headquartered in Cedar Park, Texas.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Colossal

Austin, Texas, United States
Category Company
Founded 2021
Sector Life Science
DESCRIPTION

Colossal is a biotechnology and genetic-engineering company focused on using genome editing and reproductive technologies to restore extinct species and strengthen conservation of critically endangered animals. Colossal was founded in 2021 and is headquartered in Dallas, Texas.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal